Rheumatoid Arthritis

Showing NaN - NaN of 148

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, Autoimmune Disease, Crohn Disease Trial in Canada, United States (Nivolumab)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +15 more
  • Biospecimen Collection
  • Nivolumab
  • Birmingham, Alabama
  • +46 more
Jan 31, 2023

Osteoarthritis, Rheumatoid Arthritis, Post Traumatic Arthritis Trial in United States (KINCISE(TM) Surgical Automated System)

Terminated
  • Osteoarthritis
  • +2 more
  • KINCISE(TM) Surgical Automated System
  • Roseville, California
  • +10 more
Jan 24, 2023

Rheumatoid Arthritis Trial in United States (Baricitinib, TNF Inhibitor)

Recruiting
  • Rheumatoid Arthritis
  • Flagstaff, Arizona
  • +108 more
Jan 17, 2023

Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

Completed
  • Rheumatoid Arthritis
  • ISIS 104838
  • Birmingham, Alabama
  • +30 more
Dec 1, 2022

Rheumatoid Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib)

Active, not recruiting
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +344 more
Oct 20, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo, ILV-094)

Completed
  • Rheumatoid Arthritis
  • Glendale, Arizona
  • +51 more
Sep 23, 2022

Rheumatoid Arthritis Trial in United States (Lovastatin, Placebo)

Terminated
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +14 more
Aug 9, 2022

Rheumatoid Arthritis Trial in Worldwide (Abatacept, Adalimumab, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • Fullerton, California
  • +76 more
Aug 12, 2022

Rheumatoid Arthritis Trial in United States (Certolizumab pegol)

Completed
  • Rheumatoid Arthritis
  • Certolizumab pegol
  • Covina, California
  • +8 more
Jul 26, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

Active, not recruiting
  • Rheumatoid Arthritis
  • Placebo for Adalimumab
  • +3 more
  • Birmingham, Alabama
  • +369 more
Jun 14, 2022

Systemic Lupus Erythematosus, Rheumatoid Arthritis Trial in United States (PF-06835375, Placebo)

Completed
  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +17 more
Apr 6, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
  • Rheumatoid Arthritis
  • Mesa, Arizona
  • +166 more
Mar 17, 2022

Rheumatoid Arthritis Trial in Worldwide (SAR153191 (REGN88))

Completed
  • Rheumatoid Arthritis
  • SAR153191 (REGN88)
  • Anniston, Alabama
  • +334 more
Mar 21, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)

Completed
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +187 more
Feb 14, 2022

Rheumatoid Arthritis Trial in Poland, United States (VIB4920, Placebo)

Completed
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +24 more
Feb 15, 2022

Rheumatoid Arthritis Trial in United States (Active Stimulation, Sham Stimulation, Baricitinib)

Recruiting
  • Rheumatoid Arthritis
  • Active Stimulation
  • +3 more
  • Anniston, Alabama
  • +3 more
Oct 25, 2021

Rheumatoid Arthritis Trial in Germany, United States (AMG 570, Placebo)

Completed
  • Rheumatoid Arthritis
  • AMG 570
  • Placebo
  • Anniston, Alabama
  • +3 more
Oct 7, 2021

Rheumatoid Arthritis Trial in Worldwide (PF-06410293, adalimumab)

Completed
  • Rheumatoid Arthritis
  • Bowling Green, Kentucky
  • +71 more
Sep 27, 2021

Rheumatoid Arthritis Trial in Worldwide (Canakinumab)

Completed
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +50 more
Jun 17, 2021

Rheumatoid Arthritis Trial in Worldwide (Abatacept, Methotrexate, Abatacept Placebo)

Completed
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +200 more
Jun 25, 2021

Study of Venous Endothelial Cells in Rheumatoid Arthritis

Completed
  • Rheumatoid Arthritis
    • Dallas, Texas
    • +1 more
    Mar 30, 2021

    Rheumatoid Arthritis Trial in Worldwide (Certolizumab pegol (CDP870))

    Completed
    • Rheumatoid Arthritis
    • Certolizumab pegol (CDP870)
    • Huntsville, Alabama
    • +78 more
    Nov 26, 2020

    Rheumatoid Arthritis Trial in Worldwide (GLPG0634, Placebo)

    Completed
    • Rheumatoid Arthritis
    • Huntsville, Alabama
    • +141 more
    Oct 26, 2020